Alphatec Holdings, Inc. (ATEC)
USD 10.21
(-2.3%)
USD 10.21
(-2.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 483.59 Million USD | 13.6% |
| 2022 | 354.16 Million USD | 32.83% |
| 2021 | 266.63 Million USD | 79.44% |
| 2020 | 148.58 Million USD | 27.81% |
| 2019 | 116.26 Million USD | 39.68% |
| 2018 | 83.23 Million USD | 18.93% |
| 2017 | 69.98 Million USD | -20.0% |
| 2016 | 87.48 Million USD | -31.45% |
| 2015 | 127.61 Million USD | -10.5% |
| 2014 | 142.59 Million USD | -0.87% |
| 2013 | 143.84 Million USD | 7.13% |
| 2012 | 134.27 Million USD | 2.81% |
| 2011 | 130.59 Million USD | 6.85% |
| 2010 | 122.22 Million USD | 39.98% |
| 2009 | 87.31 Million USD | -2.73% |
| 2008 | 89.76 Million USD | 48.25% |
| 2007 | 60.54 Million USD | -14.02% |
| 2006 | 70.41 Million USD | 77.62% |
| 2005 | 39.64 Million USD | 225.43% |
| 2004 | 12.18 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 7.63 Million USD | -2.59% |
| 2001 | 7.83 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 117.7 Million USD | 3.06% |
| 2024 Q3 | 191.17 Million USD | 17.82% |
| 2024 Q2 | 115.79 Million USD | -1.63% |
| 2023 FY | 402.34 Million USD | 13.6% |
| 2023 Q2 | 105.56 Million USD | -1.72% |
| 2023 Q3 | 115.28 Million USD | 9.21% |
| 2023 Q4 | 114.2 Million USD | -0.93% |
| 2023 Q1 | 107.4 Million USD | 11.35% |
| 2022 Q2 | 85.44 Million USD | 4.93% |
| 2022 Q4 | 96.45 Million USD | 6.19% |
| 2022 FY | 354.16 Million USD | 32.83% |
| 2022 Q1 | 81.42 Million USD | 4.88% |
| 2022 Q3 | 90.83 Million USD | 6.32% |
| 2021 Q2 | 69.7 Million USD | 50.23% |
| 2021 Q4 | 77.63 Million USD | 6.5% |
| 2021 FY | 266.63 Million USD | 79.44% |
| 2021 Q1 | 46.39 Million USD | 2.53% |
| 2021 Q3 | 72.89 Million USD | 4.58% |
| 2020 Q2 | 30.87 Million USD | -3.28% |
| 2020 Q3 | 40.53 Million USD | 31.28% |
| 2020 FY | 148.58 Million USD | 27.81% |
| 2020 Q4 | 45.25 Million USD | 11.63% |
| 2020 Q1 | 31.92 Million USD | -2.03% |
| 2019 Q3 | 30.92 Million USD | 10.06% |
| 2019 Q2 | 28.1 Million USD | 13.99% |
| 2019 Q1 | 24.65 Million USD | 11.54% |
| 2019 FY | 116.26 Million USD | 39.68% |
| 2019 Q4 | 32.58 Million USD | 5.36% |
| 2018 Q3 | 22.21 Million USD | 7.4% |
| 2018 Q4 | 22.1 Million USD | -0.51% |
| 2018 FY | 83.23 Million USD | 18.93% |
| 2018 Q1 | 18.46 Million USD | -0.69% |
| 2018 Q2 | 20.68 Million USD | 12.02% |
| 2017 Q4 | 18.59 Million USD | 18.93% |
| 2017 FY | 69.98 Million USD | -20.0% |
| 2017 Q3 | 15.63 Million USD | -7.0% |
| 2017 Q2 | 16.81 Million USD | -11.27% |
| 2017 Q1 | 18.94 Million USD | -10.53% |
| 2016 FY | 87.48 Million USD | -31.45% |
| 2016 Q1 | 34.28 Million USD | -5.5% |
| 2016 Q4 | 21.17 Million USD | 24.06% |
| 2016 Q3 | 17.07 Million USD | -41.85% |
| 2016 Q2 | 29.35 Million USD | -14.37% |
| 2015 Q1 | 32.23 Million USD | -8.24% |
| 2015 Q4 | 36.27 Million USD | 28.26% |
| 2015 FY | 127.61 Million USD | -10.5% |
| 2015 Q2 | 30.82 Million USD | -4.35% |
| 2015 Q3 | 28.28 Million USD | -8.25% |
| 2014 Q3 | 34.98 Million USD | 0.5% |
| 2014 FY | 142.59 Million USD | -0.87% |
| 2014 Q4 | 35.12 Million USD | 0.39% |
| 2014 Q1 | 37.66 Million USD | -6.07% |
| 2014 Q2 | 34.81 Million USD | -7.57% |
| 2013 Q4 | 40.09 Million USD | 18.66% |
| 2013 FY | 143.84 Million USD | 7.13% |
| 2013 Q3 | 33.79 Million USD | -4.59% |
| 2013 Q1 | 34.53 Million USD | -4.15% |
| 2013 Q2 | 35.41 Million USD | 2.57% |
| 2012 Q4 | 36.02 Million USD | 13.98% |
| 2012 Q1 | 31.94 Million USD | 1.28% |
| 2012 Q3 | 31.6 Million USD | -6.89% |
| 2012 FY | 134.27 Million USD | 2.81% |
| 2012 Q2 | 33.94 Million USD | 6.27% |
| 2011 Q3 | 32.17 Million USD | -2.99% |
| 2011 FY | 130.59 Million USD | 6.85% |
| 2011 Q4 | 31.54 Million USD | -1.97% |
| 2011 Q2 | 33.16 Million USD | -1.63% |
| 2011 Q1 | 33.71 Million USD | -6.75% |
| 2010 Q1 | 26.26 Million USD | 16.87% |
| 2010 FY | 122.22 Million USD | 39.98% |
| 2010 Q2 | 30.99 Million USD | 18.0% |
| 2010 Q4 | 36.15 Million USD | 23.49% |
| 2010 Q3 | 29.27 Million USD | -5.54% |
| 2009 Q4 | 22.47 Million USD | 4.93% |
| 2009 Q2 | 21.8 Million USD | 0.9% |
| 2009 Q1 | 21.61 Million USD | 3.55% |
| 2009 FY | 87.31 Million USD | -2.73% |
| 2009 Q3 | 21.41 Million USD | -1.79% |
| 2008 Q2 | 19.15 Million USD | -35.87% |
| 2008 FY | 89.76 Million USD | 48.25% |
| 2008 Q4 | 20.87 Million USD | 5.09% |
| 2008 Q1 | 29.87 Million USD | 107.06% |
| 2008 Q3 | 19.86 Million USD | 3.69% |
| 2007 FY | 60.54 Million USD | -14.02% |
| 2007 Q2 | 12.53 Million USD | -17.98% |
| 2007 Q3 | 18.3 Million USD | 46.07% |
| 2007 Q4 | 14.42 Million USD | -21.2% |
| 2007 Q1 | 15.28 Million USD | -32.57% |
| 2006 FY | 70.41 Million USD | 77.62% |
| 2006 Q4 | 22.66 Million USD | 38.52% |
| 2006 Q1 | 14.73 Million USD | 125.68% |
| 2006 Q2 | 16.66 Million USD | 13.14% |
| 2006 Q3 | 16.36 Million USD | -1.82% |
| 2005 Q2 | 10 Million USD | 0.0% |
| 2005 Q4 | -57.36 Million USD | -458.56% |
| 2005 Q1 | - USD | 100.0% |
| 2005 Q3 | 16 Million USD | 60.0% |
| 2005 FY | 39.64 Million USD | 225.43% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | -17.64 Million USD | 0.0% |
| 2004 FY | 12.18 Million USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2002 FY | 7.63 Million USD | -2.59% |
| 2001 FY | 7.83 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -4208.607% |
| Cerus Corporation | 143.15 Million USD | -237.814% |
| OrthoPediatrics Corp. | 137.01 Million USD | -252.942% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -4156.7% |
| Talis Biomedical Corporation | 67.18 Million USD | -619.79% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -1838.579% |
| Inogen, Inc. | 236.08 Million USD | -104.841% |
| Spectral AI, Inc. | 20.86 Million USD | -2217.859% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -763.614% |
| CVRx, Inc. | 76.14 Million USD | -535.126% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -13607.442% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -3772.192% |
| Orthofix Medical Inc. | 667.42 Million USD | 27.543% |
| Venus Concept Inc. | 80.47 Million USD | -500.922% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -754.746% |
| Bioventus Inc. | 409.91 Million USD | -17.974% |
| BrainsWay Ltd. | 28.01 Million USD | -1626.026% |
| Envoy Medical, Inc. | 17.89 Million USD | -2601.967% |
| electroCore, Inc. | 32.03 Million USD | -1409.781% |
| IceCure Medical Ltd | 16.87 Million USD | -2765.596% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -1039.701% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -2642.569% |
| MaxCyte, Inc. | 84.84 Million USD | -469.978% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -3796.286% |
| Nexalin Technology, Inc. | 5.78 Million USD | -8264.785% |
| PAVmed Inc | 64.82 Million USD | -645.982% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -846.783% |
| RxSight, Inc. | 103.85 Million USD | -365.67% |
| Sight Sciences, Inc. | 126.44 Million USD | -282.445% |
| SI-BONE, Inc. | 156.35 Million USD | -209.303% |
| TELA Bio, Inc. | 84.18 Million USD | -474.433% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -590.302% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -137.798% |
| LivaNova PLC | 843.54 Million USD | 42.671% |
| 908 Devices Inc. | 68.08 Million USD | -610.338% |
| Nemaura Medical Inc. | 7.13 Million USD | -6674.217% |
| NeuroPace, Inc. | 75.29 Million USD | -542.263% |
| LENSAR, Inc. | 33.33 Million USD | -1350.678% |
| Apyx Medical Corporation | 51.01 Million USD | -847.897% |
| Cutera, Inc. | 197.72 Million USD | -144.582% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -1851.487% |
| BioSig Technologies, Inc. | 28.53 Million USD | -1595.051% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -152.565% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -1241.093% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 42.18% |
| Axonics, Inc. | 270.2 Million USD | -78.976% |
| Outset Medical, Inc. | 198.77 Million USD | -143.295% |
| IRIDEX Corporation | 31.81 Million USD | -1420.079% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -168.339% |
| IRadimed Corporation | 30.12 Million USD | -1505.421% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -5568.05% |
| INVO Bioscience, Inc. | 7.85 Million USD | -6057.901% |
| Telesis Bio, Inc. | 63.48 Million USD | -661.704% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -391.197% |
| Varex Imaging Corporation | 224.8 Million USD | -115.124% |
| Quipt Home Medical Corp. | 148.66 Million USD | -225.289% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -4025.207% |
| Pulmonx Corporation | 112.68 Million USD | -329.152% |
| Dynatronics Corporation | 9.9 Million USD | -4780.871% |
| Modular Medical, Inc. | 17.52 Million USD | -2658.845% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -2295.591% |
| Semler Scientific, Inc. | 38.94 Million USD | -1141.778% |
| InMode Ltd. | 215.68 Million USD | -124.22% |
| Bruker Corporation | 1.07 Billion USD | 55.073% |
| Cytosorbents Corporation | 48.33 Million USD | -900.475% |
| DexCom, Inc. | 1.69 Billion USD | 71.405% |
| Align Technology, Inc. | 2.07 Billion USD | 76.715% |
| Viveve Medical, Inc. | 22.17 Million USD | -2081.022% |
| ZimVie Inc. | 275.12 Million USD | -75.773% |
| Movano Inc. | 29.69 Million USD | -1528.825% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -252.294% |
| Nexalin Technology, Inc. | 5.78 Million USD | -8264.785% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -13607.442% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 19.524% |
| Profound Medical Corp. | 33.6 Million USD | -1339.145% |
| Insulet Corporation | 939.9 Million USD | 48.548% |
| enVVeno Medical Corporation | 25.23 Million USD | -1816.15% |
| Surmodics, Inc. | 98.69 Million USD | -389.982% |
| iCAD, Inc. | 22.22 Million USD | -2075.919% |
| Nuwellis, Inc. | 22.61 Million USD | -2038.584% |
| Biotricity, Inc. | 17.18 Million USD | -2714.144% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -8.457% |
| Aethlon Medical, Inc. | 12.27 Million USD | -3838.893% |
| InspireMD, Inc. | 22.95 Million USD | -2007.181% |
| PAVmed Inc. | 64.82 Million USD | -645.982% |
| BIOLASE, Inc. | 34.66 Million USD | -1295.222% |
| Beyond Air, Inc. | 61.7 Million USD | -683.789% |
| FONAR Corporation | 28.6 Million USD | -1590.625% |
| AxoGen, Inc. | 149.33 Million USD | -223.832% |
| Vivani Medical, Inc. | 26.96 Million USD | -1693.429% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -173.077% |
| Inari Medical, Inc. | 448.59 Million USD | -7.803% |
| UFP Technologies, Inc. | 58.08 Million USD | -732.512% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -9714.07% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -7553.939% |
| Tenon Medical, Inc. | 16.96 Million USD | -2750.059% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -6441.296% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -996.523% |
| AdaptHealth Corp. | 1.07 Billion USD | 55.138% |
| Sintx Technologies, Inc. | 15.2 Million USD | -3081.356% |
| NanoVibronix, Inc. | 4.97 Million USD | -9624.472% |
| Quanterix Corporation | 118.1 Million USD | -309.482% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -4025.207% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -3248.553% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -23.158% |
| TransMedics Group, Inc. | 182.82 Million USD | -164.521% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -1623.136% |
| NeuroMetrix, Inc. | 11.09 Million USD | -4257.157% |
| Hyperfine, Inc. | 52.87 Million USD | -814.658% |
| Establishment Labs Holdings Inc. | 172 Million USD | -181.157% |
| Biomerica, Inc. | 6.97 Million USD | -6830.324% |
| Bone Biologics Corporation | 9.42 Million USD | -5029.216% |
| AVITA Medical, Inc. | 80.77 Million USD | -498.666% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -4590.019% |
| Silk Road Medical, Inc | 186.35 Million USD | -159.501% |